Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|September 18, 1997
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcomaP H Frissen, F de Wolf, P Reiss, et al.
Immunology Letters|April 15, 1999
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionO Pontesilli, S Kerkhof-Garde, N G Pakker, et al.
British Journal of Haematology|September 1, 1987
Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infectionJ van der Lelie, J M Lange, J J Vos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2001
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapyE H Gisolf, R M van Praag, S Jurriaans, et al.
AIDS (London, England)|January 1, 1991
Attitudes of health-care workers towards AIDS at three Dutch hospitalsJ G Storosum, H N Sno, H F Schalken, et al.
AIDS (London, England)|January 6, 1999
Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapyS Kostense, F M Raaphorst, D W Notermans, et al.
Clinical and Experimental Immunology|May 1, 1986
Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitroH J Schuurman, R W Hendriks, J M Lange, et al.
AIDS (London, England)|December 1, 1992
The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I studyR van Leeuwen, J M Lange, E K Hussey, et al.
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
The Journal of Infectious Diseases|June 1, 1995
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)R Schuurman, M Nijhuis, R van Leeuwen, et al.
Pageof 13